We are developing a select portfolio of complex generic formulations where the complexity is a challenge either due to the API or the formulation or both. For formulations that require vertical integration and economy of scale, we will leverage our large-scale API manufacturing infrastructure.
CONTACT
Group Companies
GENERIC FORMULATIONS
Strategy: Portfolio
Our products
The dosage forms in our portfolio include:
Oral Solids (Potent and Non-Potent)
Injectable
Device Dependent Formulations
PRESS RELEASES
CORPORATE GOVERNANCE
